معرفی
Kevin Bajerke is a researcher at the Department of Chemistry, Stockholm University, focusing on the development of methods for fluorine-18 labelling of small peptide drug conjugates (PDC) and their metabolites. His work targets alkylating anti-cancer drugs for clinical imaging via positron emission tomography (PET).
- Research Group: Kalman Szabo group
- Key Techniques: Transition-metal catalysis and organocatalysis targeting fluorine and boron-containing organic molecules
- Email: kevin.bajerke@su.se
۰مقاله منتشرشده
